Kazakhstan Seeks to Reduce Dependence on Imported Medicines with New Pharmaceutical Plants
Kazakhstan plans to begin producing almost 500 types of medicine domestically by 2034 under eight investment projects worth approximately $862
Read the full story at The Times of Central AsiaOpen in the live monitor